Interplay between age and disease-modifying treatments in influencing infection risk in multiple sclerosis.

Sarah Lena Susanna Jacober,Giulio Disanto,Rosaria Sacco, Delania Meng,Giulia Mallucci,Ursula Candrian,Sebastiano Semini,Massimiliano Tiberti,Claudio Gobbi,Chiara Zecca

Multiple sclerosis (Houndmills, Basingstoke, England)（2023）

引用 0|浏览9

暂无评分

摘要

Treatment with MAB and oral DMTs is associated with higher incidence of infections, with a stronger effect in young MS patients. Disability appears the main predictor of severe infections regardless of treatment.

查看译文

关键词

Age, disease-modifying treatments, infection risk, multiple sclerosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要